TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04014296 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT06214689 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06214689 — Predictive Biomarker (PRD): POU5F1 mRNA
Genes: POU5F1; OCT3; OCT4; OTF3
Study NCT06061315 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06620835 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03923907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04687787 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT06650527 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06249854 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04927429 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06043232 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05557110 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06653907 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05779137 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06595758 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06595758 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05523414 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study NCT04681781 — Predictive Biomarker (PRD): SLC13A5 mRNA
Genes: SLC13A5; NACT
Study NCT06654882 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06098872 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT06098872 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT05706896 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00720603 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05608174 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06450652 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06450652 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06600568 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04404387 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05597085 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05176626 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05031286 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05774431 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study NCT06591533 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06312761 — Predictive Biomarker (PRD): UGT2B17 mRNA
Genes: UGT2B17
Study NCT06312761 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06598488 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05354583 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06600698 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04426877 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06602570 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06599034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06590545 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06594211 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06594211 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06601738 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04943302 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04712110 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00073216 — Predictive Biomarker (PRD): PLG mRNA
Genes: PLG
Study NCT00073216 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00002155 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05093374 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05930028 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05759429 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05403437 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT06623240 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06586047 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05744037 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05744037 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06148376 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05715931 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06326411 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06279767 — Safety Biomarker (SAF): Hypoxanthine-guanine phosphoribosyltransferase
Genes: HPRT1; HPRT
Study NCT06279767 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT06652685 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05005130 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05663216 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05663216 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05940493 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05940493 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT04736576 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04736576 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04874025 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04874025 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06597006 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06597006 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06665776 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05514314 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06653686 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06653686 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04613323 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05112406 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06495203 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06495203 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04813380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04813380 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study NCT05122806 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05122806 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05249114 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT05132556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04842175 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00000861 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06038539 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06038539 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03770546 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05292417 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06435000 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study NCT06472427 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05736432 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06514950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06584006 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00002106 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04774393 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04774393 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06234761 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05045586 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03664466 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03664466 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06459505 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04735471 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04655365 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05061459 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04868877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04868877 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06622824 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT00385957 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06462794 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06287580 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04856046 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT05546125 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04867616 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04919642 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05431933 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06651853 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06652893 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06654817 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06655831 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06141369 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05096819 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06588790 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05497596 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT06603935 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05823480 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT04262687 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06211361 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06597708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06597708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05141760 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06602687 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06590363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05074979 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05408325 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05408325 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT05162976 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04852874 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05451875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05683457 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06351670 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05601648 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT06102824 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05816889 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04968002 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04968002 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05484154 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT05417646 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05417646 — Predictive Biomarker (PRD): HNF1A mRNA
Genes: HNF1A; TCF1
Study NCT05776836 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05581498 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05581498 — Safety Biomarker (SAF): BDNF
Study NCT05035862 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05035862 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04911660 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04117074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06337565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05960227 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05559710 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05454371 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05454371 — Predictive Biomarker (PRD): CD101 mRNA
Genes: CD101; EWI101; IGSF2; V7
Study NCT05454371 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT05454371 — Predictive Biomarker (PRD): KCNH2 mRNA
Genes: KCNH2; ERG; ERG1; HERG
Study NCT05216042 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT06647979 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study NCT06647745 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05617638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06060613 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT05780775 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06388265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05721248 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05003505 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05003505 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04889001 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT05807581 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05807581 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05807581 — Safety Biomarker (SAF): BDNF
Study NCT05387200 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06561178 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04994951 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06425419 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05502705 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05502705 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT05945849 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT06559189 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06559189 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT00086112 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03458221 — Predictive Biomarker (PRD): TRIP10 mRNA
Genes: TRIP10; CIP4; STOT; STP
Study NCT03458221 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT06228053 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study NCT06619405 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06620874 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06619743 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05580588 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06472050 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06005870 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05082610 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study NCT01691261 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT06171321 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06622551 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT05186038 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05186038 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT04683939 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT06105177 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04184882 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05459181 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06279208 — Predictive Biomarker (PRD): DYRK1A mRNA
Genes: DYRK1A; DYRK; MNB; MNBH
Study NCT06494358 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06267651 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06267651 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06064279 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04837716 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06568809 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04439097 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05411029 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04935710 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT06521125 — Predictive Biomarker (PRD): MUC5B mRNA
Genes: MUC5B; MUC5
Study NCT06521125 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT02809235 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT05562999 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT06651450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06119048 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06119048 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06385873 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05767177 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT06586099 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06586099 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00001029 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04848792 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study NCT04848792 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT06591806 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study NCT05172024 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06260033 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06260033 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06591520 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06595498 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06604377 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06604377 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06603337 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06586437 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06387407 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT06586580 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05075811 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05432947 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05153967 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05153967 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study NCT06590194 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06312111 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06088069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05462847 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05462847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05860946 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT05533606 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03746912 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06208748 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01529892 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT06275893 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT05577507 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05577507 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT05577507 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05773664 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT00000754 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06552572 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05895942 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT06194591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06194591 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05924672 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27